These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15878263)

  • 1. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
    Dobay O; Rozgonyi F; Amyes SG
    Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
    Gulay Z; Ozbek OA; Bicmen M; Gur D
    Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
    Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
    Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
    Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M
    Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
    Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
    Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ; Jenkins SG
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
    Ikenaga M; Kosowska-Shick K; Gotoh K; Hidaka H; Koga H; Masunaga K; Nagai K; Tsumura N; Appelbaum PC; Matsuishi T
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):16-22. PubMed ID: 18068325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000-07).
    de la Pedrosa EG; Baquero F; Loza E; Nadal-Serrano JM; Fenoll A; Del Campo R; Cantón R
    J Antimicrob Chemother; 2009 Dec; 64(6):1165-9. PubMed ID: 19837717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
    Farrell DJ; Couturier C; Hryniewicz W
    Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the DUEL 2 study.
    Neeleman C; De Valk JA; Klaassen CH; Meijers S; Mouton JW
    Clin Microbiol Infect; 2005 Apr; 11(4):312-8. PubMed ID: 15760429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
    Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
    J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
    Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
    Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rise of Streptococcus pneumoniae isolates containing both erm(B) and mef(E) genes from an adult tertiary care community hospital system.
    DiPersio LP; DiPersio JR; Beach JA; DeFine LA
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):327-31. PubMed ID: 16626911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003.
    Souli M; Volonakis K; Kapaskelis A; Galani I; Grammelis V; Vorou R; Tsivra M; Chryssouli Z; Katsala D; Giamarellou H
    Clin Microbiol Infect; 2007 Jan; 13(1):70-7. PubMed ID: 17184290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.
    van der Linden M; Al-Lahham A; Haupts S; Reinert RR
    Antimicrob Agents Chemother; 2007 May; 51(5):1830-4. PubMed ID: 17325214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.